Profound bradycardia after addition of diltiazem to a beta blocker.
作者信息
Hassell A B, Creamer J E
机构信息
Department of Medicine, University of South Manchester.
出版信息
BMJ. 1989 Mar 11;298(6674):675. doi: 10.1136/bmj.298.6674.675.
Abstract
摘要
相似文献
1
Profound bradycardia after addition of diltiazem to a beta blocker.在β受体阻滞剂基础上加用维拉帕米后出现严重心动过缓。
BMJ. 1989 Mar 11;298(6674):675. doi: 10.1136/bmj.298.6674.675.
2
Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.由地尔硫䓬、维拉帕米和/或β-肾上腺素能阻断药物引起的严重窦性心动过缓。
J La State Med Soc. 2004 Nov-Dec;156(6):327-31.
3
Symptomatic bradycardia induced by the combination of oral diltiazem and beta blockers.口服地尔硫䓬与β受体阻滞剂联合使用引起的症状性心动过缓。
Clin Cardiol. 1991 Apr;14(4):314-6. doi: 10.1002/clc.4960140406.
4
Combination of oral diltiazem and beta blockers.口服地尔硫䓬与β受体阻滞剂联合使用。
Clin Cardiol. 1991 Sep;14(9):A29. doi: 10.1002/clc.4960140922.
5
6
[Shock during combined administration of diltiazem and adrenergic beta receptor blockaders].[地尔硫䓬与肾上腺素能β受体阻滞剂联合应用时的休克]
Rev Med Interne. 1992 Jan-Feb;13(1):80. doi: 10.1016/s0248-8663(05)80016-5.
7
Life-threatening bradycardic reactions due to beta blocker-diltiazem interactions.由于β受体阻滞剂与地尔硫䓬相互作用导致的危及生命的心动过缓反应。
Isr J Med Sci. 1992 May;28(5):292-4.
8
Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后症状性心动过缓和低血压的临床意义及诱发因素。
Am J Cardiol. 1994 Dec 1;74(11):1085-8. doi: 10.1016/0002-9149(94)90456-1.
9
[Adverse effects of a diltiazem-beta-blocker combination].[地尔硫䓬 - β受体阻滞剂联合用药的不良反应]
Presse Med. 1984 May 26;13(22):1396.
10
Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
Med J Aust. 1998 Oct 19;169(8):425-7.
引用本文的文献
1
Adverse effects using combined rate-slowing antihypertensive agents.联合使用降心率抗高血压药物的不良反应。
J Clin Hypertens (Greenwich). 2011 Jul;13(7):529-32. doi: 10.1111/j.1751-7176.2011.00486.x. Epub 2011 Jun 20.
2
Are beta blockers and nifedipine safe?β受体阻滞剂和硝苯地平安全吗？
BMJ. 1989 Jun 10;298(6687):1584. doi: 10.1136/bmj.298.6687.1584-a.
3
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.地尔硫䓬。对其药理特性和治疗用途的重新评估。
Drugs. 1990 May;39(5):757-806. doi: 10.2165/00003495-199039050-00009.
本文引用的文献
1
The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.地尔硫䓬与普萘洛尔单独及联合应用对稳定型劳力性心绞痛患者运动能力和左心室功能的影响：一项双盲、随机、安慰剂对照研究。
Circulation. 1983 Sep;68(3):560-7. doi: 10.1161/01.cir.68.3.560.
2
Calcium-entry blockage: basic concepts and clinical implications.钙内流阻滞：基本概念与临床意义
Circulation. 1987 Jun;75(6 Pt 2):V1-162.
3
Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris.
Clin Cardiol. 1987 Feb;10(2):115-23. doi: 10.1002/clc.4960100207.
4
5
Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination.
J Am Coll Cardiol. 1986 Feb;7(2):329-35. doi: 10.1016/s0735-1097(86)80500-9.
Zotero 插件